| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E-Selectin | 30 | 2022 | 577 | 6.510 |
Why?
|
| Fucose | 13 | 2022 | 124 | 2.850 |
Why?
|
| Fucosyltransferases | 12 | 2022 | 119 | 2.370 |
Why?
|
| Mesenchymal Stem Cells | 13 | 2021 | 1620 | 2.280 |
Why?
|
| Cell Movement | 28 | 2019 | 5220 | 2.190 |
Why?
|
| L-Selectin | 16 | 2017 | 213 | 2.170 |
Why?
|
| Glycosyltransferases | 7 | 2018 | 113 | 2.080 |
Why?
|
| Glycomics | 5 | 2019 | 121 | 1.890 |
Why?
|
| Polysaccharides | 13 | 2021 | 1050 | 1.730 |
Why?
|
| Ligands | 31 | 2022 | 3301 | 1.670 |
Why?
|
| Hematopoietic Stem Cells | 23 | 2017 | 3369 | 1.480 |
Why?
|
| Cell Adhesion | 27 | 2022 | 3137 | 1.360 |
Why?
|
| Selectins | 5 | 2016 | 102 | 1.100 |
Why?
|
| Lymphocytes | 16 | 2008 | 2615 | 1.070 |
Why?
|
| T-Lymphocytes | 15 | 2022 | 10140 | 0.890 |
Why?
|
| Endothelial Cells | 6 | 2022 | 3433 | 0.860 |
Why?
|
| Glycoproteins | 7 | 2023 | 2259 | 0.840 |
Why?
|
| Tongue Neoplasms | 1 | 2023 | 179 | 0.790 |
Why?
|
| Bone Marrow Cells | 8 | 2017 | 2515 | 0.790 |
Why?
|
| Myeloid Cells | 3 | 2014 | 801 | 0.780 |
Why?
|
| Membrane Glycoproteins | 13 | 2018 | 3768 | 0.780 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 7 | 2014 | 643 | 0.750 |
Why?
|
| Glycosylation | 10 | 2020 | 1125 | 0.730 |
Why?
|
| Heparitin Sulfate | 2 | 2018 | 224 | 0.660 |
Why?
|
| Neuraminidase | 5 | 2017 | 209 | 0.640 |
Why?
|
| Oligosaccharides | 2 | 2018 | 417 | 0.640 |
Why?
|
| Blotting, Western | 7 | 2015 | 5180 | 0.640 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2018 | 102 | 0.610 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2020 | 675 | 0.610 |
Why?
|
| Cell Communication | 5 | 2021 | 1619 | 0.590 |
Why?
|
| Protein Engineering | 4 | 2019 | 543 | 0.570 |
Why?
|
| P-Selectin | 7 | 2009 | 600 | 0.570 |
Why?
|
| Leukocytes | 6 | 2020 | 2036 | 0.570 |
Why?
|
| Immunologic Surveillance | 1 | 2017 | 93 | 0.570 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2018 | 495 | 0.570 |
Why?
|
| Biotechnology | 1 | 2018 | 278 | 0.560 |
Why?
|
| Bone Marrow Transplantation | 12 | 2004 | 2760 | 0.540 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 2704 | 0.530 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2018 | 1821 | 0.530 |
Why?
|
| Chemokines | 5 | 2018 | 948 | 0.520 |
Why?
|
| Graft vs Host Disease | 13 | 2020 | 2948 | 0.520 |
Why?
|
| Skin | 8 | 2004 | 4324 | 0.510 |
Why?
|
| Models, Immunological | 1 | 2017 | 527 | 0.490 |
Why?
|
| Acetylglucosamine | 3 | 2009 | 191 | 0.470 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2014 | 43 | 0.470 |
Why?
|
| Receptors, Lymphocyte Homing | 5 | 2005 | 143 | 0.470 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 139 | 0.460 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2019 | 1239 | 0.460 |
Why?
|
| Cell Adhesion Molecules | 6 | 2006 | 1599 | 0.450 |
Why?
|
| Isoenzymes | 1 | 2018 | 1720 | 0.450 |
Why?
|
| Endothelium, Vascular | 7 | 2009 | 4454 | 0.440 |
Why?
|
| Hematopoiesis | 6 | 2022 | 2055 | 0.440 |
Why?
|
| Chemokine CXCL12 | 4 | 2009 | 462 | 0.440 |
Why?
|
| Leukocytosis | 1 | 2014 | 247 | 0.430 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 1834 | 0.430 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 88 | 0.420 |
Why?
|
| Endothelium | 7 | 2020 | 776 | 0.420 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 439 | 0.420 |
Why?
|
| Glycoconjugates | 3 | 2022 | 88 | 0.410 |
Why?
|
| Transplantation, Heterologous | 11 | 2016 | 2381 | 0.410 |
Why?
|
| Chemokine CCL5 | 2 | 2009 | 209 | 0.410 |
Why?
|
| Bone and Bones | 2 | 2016 | 2574 | 0.410 |
Why?
|
| Animals | 68 | 2022 | 168358 | 0.400 |
Why?
|
| Cell Line | 14 | 2020 | 15982 | 0.400 |
Why?
|
| Antigens, CD34 | 3 | 2011 | 656 | 0.400 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 2985 | 0.390 |
Why?
|
| Peroxidase | 1 | 2014 | 608 | 0.390 |
Why?
|
| Neoplastic Stem Cells | 4 | 2021 | 1375 | 0.390 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 21 | 2022 | 5404 | 0.370 |
Why?
|
| Monocytes | 2 | 2018 | 2583 | 0.360 |
Why?
|
| Career Choice | 1 | 2016 | 742 | 0.360 |
Why?
|
| CHO Cells | 6 | 2015 | 1404 | 0.350 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 831 | 0.350 |
Why?
|
| Dendritic Cells | 2 | 2018 | 2728 | 0.350 |
Why?
|
| Cells, Cultured | 13 | 2020 | 19223 | 0.340 |
Why?
|
| Cricetinae | 6 | 2015 | 2468 | 0.330 |
Why?
|
| Graft vs Tumor Effect | 2 | 2006 | 71 | 0.330 |
Why?
|
| Bioethics | 1 | 2010 | 118 | 0.320 |
Why?
|
| Chemotaxis | 2 | 2009 | 602 | 0.320 |
Why?
|
| Protein Binding | 7 | 2019 | 9381 | 0.320 |
Why?
|
| Humans | 116 | 2023 | 739219 | 0.320 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 843 | 0.320 |
Why?
|
| Neoplasm Proteins | 3 | 2011 | 3693 | 0.320 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 96 | 0.310 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 12064 | 0.310 |
Why?
|
| Cell Differentiation | 9 | 2021 | 11471 | 0.300 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 889 | 0.300 |
Why?
|
| Hyaluronic Acid | 2 | 2018 | 486 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 4013 | 0.300 |
Why?
|
| Fetal Blood | 2 | 2022 | 1316 | 0.300 |
Why?
|
| Colonic Neoplasms | 4 | 2008 | 2528 | 0.300 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 185 | 0.290 |
Why?
|
| Leukocyte Rolling | 2 | 2005 | 72 | 0.280 |
Why?
|
| Mice | 32 | 2022 | 80995 | 0.280 |
Why?
|
| Integrin alpha4beta1 | 3 | 2011 | 120 | 0.270 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2004 | 272 | 0.270 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1445 | 0.260 |
Why?
|
| Coculture Techniques | 5 | 2018 | 1343 | 0.260 |
Why?
|
| Lymph Nodes | 9 | 2008 | 3453 | 0.250 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 1866 | 0.250 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2011 | 908 | 0.250 |
Why?
|
| Immunophenotyping | 4 | 2018 | 1859 | 0.240 |
Why?
|
| Neoplasms | 6 | 2021 | 21499 | 0.240 |
Why?
|
| Transplantation Immunology | 2 | 2006 | 547 | 0.240 |
Why?
|
| Stress, Physiological | 2 | 2009 | 1402 | 0.240 |
Why?
|
| Stress, Mechanical | 4 | 2015 | 1682 | 0.230 |
Why?
|
| Dermatitis, Contact | 1 | 2003 | 129 | 0.230 |
Why?
|
| N-Acetylneuraminic Acid | 3 | 2016 | 175 | 0.220 |
Why?
|
| Stromal Cells | 2 | 2008 | 1350 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2011 | 8395 | 0.220 |
Why?
|
| Bone Marrow | 3 | 2016 | 2933 | 0.220 |
Why?
|
| Transplantation Conditioning | 10 | 2005 | 1595 | 0.220 |
Why?
|
| Methylprednisolone | 2 | 1995 | 388 | 0.220 |
Why?
|
| Biological Assay | 1 | 2006 | 653 | 0.210 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 16624 | 0.210 |
Why?
|
| Transplantation, Homologous | 14 | 2020 | 4768 | 0.210 |
Why?
|
| Immunotherapy | 2 | 2018 | 4389 | 0.210 |
Why?
|
| Neutrophils | 2 | 2016 | 3698 | 0.210 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1294 | 0.210 |
Why?
|
| Mucins | 2 | 2023 | 563 | 0.210 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2022 | 171 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2021 | 1989 | 0.200 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2006 | 377 | 0.200 |
Why?
|
| Research | 1 | 2010 | 2001 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3323 | 0.190 |
Why?
|
| Cricetulus | 2 | 2015 | 814 | 0.180 |
Why?
|
| Flow Cytometry | 7 | 2018 | 5959 | 0.180 |
Why?
|
| GATA3 Transcription Factor | 1 | 2020 | 157 | 0.180 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 131 | 0.180 |
Why?
|
| Galectins | 1 | 2022 | 266 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 140 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 5 | 2004 | 225 | 0.170 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2020 | 127 | 0.170 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 2005 | 905 | 0.170 |
Why?
|
| Drug Repositioning | 1 | 2021 | 232 | 0.170 |
Why?
|
| Fibronectins | 3 | 2017 | 723 | 0.170 |
Why?
|
| Leukemia | 2 | 2022 | 1503 | 0.160 |
Why?
|
| Thrombocytopenia | 4 | 2022 | 1170 | 0.160 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2011 | 705 | 0.160 |
Why?
|
| Immune Tolerance | 4 | 2020 | 2257 | 0.160 |
Why?
|
| Testis | 1 | 2022 | 799 | 0.160 |
Why?
|
| Transplantation Chimera | 5 | 2005 | 610 | 0.160 |
Why?
|
| Amino Sugars | 1 | 2018 | 40 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3629 | 0.160 |
Why?
|
| Shear Strength | 2 | 2009 | 165 | 0.160 |
Why?
|
| Cryopreservation | 2 | 2018 | 650 | 0.160 |
Why?
|
| Cell Survival | 4 | 2018 | 5873 | 0.150 |
Why?
|
| Exanthema | 1 | 2002 | 491 | 0.150 |
Why?
|
| Neoplasm Metastasis | 4 | 2019 | 4832 | 0.150 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 328 | 0.150 |
Why?
|
| Prostaglandins F | 1 | 2017 | 81 | 0.150 |
Why?
|
| Manganese | 1 | 2020 | 407 | 0.150 |
Why?
|
| Click Chemistry | 1 | 2018 | 95 | 0.150 |
Why?
|
| Papio | 8 | 2002 | 656 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2020 | 1369 | 0.150 |
Why?
|
| Major Histocompatibility Complex | 4 | 1985 | 935 | 0.150 |
Why?
|
| Thoracic Duct | 2 | 1995 | 63 | 0.150 |
Why?
|
| Stem Cells | 2 | 2010 | 3571 | 0.150 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 774 | 0.150 |
Why?
|
| Acute Disease | 6 | 2020 | 7127 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2019 | 2714 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1153 | 0.140 |
Why?
|
| Antigens, Surface | 3 | 2001 | 1667 | 0.140 |
Why?
|
| Transfection | 4 | 2016 | 5884 | 0.140 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2016 | 105 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1212 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2005 | 1800 | 0.130 |
Why?
|
| Education, Professional | 1 | 2016 | 54 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2016 | 3744 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2016 | 211 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 685 | 0.130 |
Why?
|
| Thrombosis | 4 | 2001 | 2962 | 0.130 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2015 | 126 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 691 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2014 | 4205 | 0.130 |
Why?
|
| Hematologic Neoplasms | 7 | 2005 | 1801 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 6 | 2016 | 21859 | 0.120 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 726 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2021 | 1145 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14555 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 594 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 2518 | 0.120 |
Why?
|
| Immunosuppressive Agents | 4 | 2006 | 4143 | 0.120 |
Why?
|
| Tumor Escape | 1 | 2017 | 348 | 0.120 |
Why?
|
| Biocatalysis | 1 | 2014 | 166 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2020 | 2498 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2016 | 263 | 0.120 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1348 | 0.120 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 5521 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2021 | 1343 | 0.110 |
Why?
|
| Kinetics | 5 | 2016 | 6473 | 0.110 |
Why?
|
| Vaccines | 1 | 2021 | 802 | 0.110 |
Why?
|
| Antigens, CD1 | 2 | 2008 | 435 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2018 | 13006 | 0.110 |
Why?
|
| Refrigeration | 1 | 2011 | 28 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 1993 | 2865 | 0.100 |
Why?
|
| Antigens | 1 | 2018 | 1462 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2017 | 2004 | 0.100 |
Why?
|
| Epitopes | 3 | 2008 | 2558 | 0.100 |
Why?
|
| Antigens, Neoplasm | 4 | 2005 | 1977 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 4400 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2014 | 2257 | 0.100 |
Why?
|
| Chemokines, CXC | 2 | 2006 | 422 | 0.100 |
Why?
|
| Skull | 1 | 2016 | 809 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2011 | 3142 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2011 | 62 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1513 | 0.100 |
Why?
|
| Benzylamines | 2 | 2009 | 226 | 0.100 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 248 | 0.100 |
Why?
|
| Lymphopenia | 1 | 1993 | 286 | 0.100 |
Why?
|
| Bioengineering | 1 | 2012 | 98 | 0.100 |
Why?
|
| Psoriasis | 2 | 1989 | 888 | 0.100 |
Why?
|
| Body Size | 1 | 2014 | 457 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2017 | 3300 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2503 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2011 | 2505 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1661 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2199 | 0.090 |
Why?
|
| Colitis | 1 | 2018 | 1146 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 1100 | 0.090 |
Why?
|
| HL-60 Cells | 2 | 2001 | 361 | 0.090 |
Why?
|
| Organ Transplantation | 2 | 2016 | 1131 | 0.090 |
Why?
|
| Lymphocyte Depletion | 4 | 2006 | 609 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1734 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 215 | 0.090 |
Why?
|
| Complement C4 | 3 | 1985 | 257 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2016 | 1533 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 237 | 0.090 |
Why?
|
| Mutation | 1 | 2014 | 29659 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 728 | 0.090 |
Why?
|
| Microscopy | 1 | 2015 | 899 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 2015 | 798 | 0.090 |
Why?
|
| Sialic Acids | 2 | 2000 | 129 | 0.080 |
Why?
|
| Interleukin-2 | 3 | 2003 | 1884 | 0.080 |
Why?
|
| Chondroitin Sulfates | 1 | 2009 | 185 | 0.080 |
Why?
|
| Endothelium, Lymphatic | 1 | 1988 | 59 | 0.080 |
Why?
|
| Transplantation, Autologous | 6 | 2004 | 2119 | 0.080 |
Why?
|
| Complement Factor B | 2 | 1985 | 72 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 791 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 8 | 2008 | 9259 | 0.080 |
Why?
|
| Lymph | 1 | 2008 | 80 | 0.080 |
Why?
|
| Peyer's Patches | 1 | 1988 | 122 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 306 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2016 | 2741 | 0.080 |
Why?
|
| Rheology | 1 | 2009 | 345 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6319 | 0.080 |
Why?
|
| Histocompatibility | 3 | 2004 | 331 | 0.080 |
Why?
|
| Blood Coagulation Disorders | 2 | 2000 | 337 | 0.080 |
Why?
|
| Solubility | 1 | 2008 | 1083 | 0.070 |
Why?
|
| Cell Transplantation | 2 | 2018 | 478 | 0.070 |
Why?
|
| Swine, Miniature | 4 | 2002 | 954 | 0.070 |
Why?
|
| Swine | 9 | 2002 | 5893 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2521 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2008 | 1378 | 0.070 |
Why?
|
| Cytokines | 7 | 2022 | 7296 | 0.070 |
Why?
|
| Sialyltransferases | 1 | 2006 | 75 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1995 | 1833 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1357 | 0.070 |
Why?
|
| Nitroimidazoles | 1 | 2007 | 106 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2008 | 669 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 4424 | 0.070 |
Why?
|
| Lymphocyte Transfusion | 2 | 2005 | 234 | 0.070 |
Why?
|
| Chemokines, CC | 1 | 2006 | 291 | 0.070 |
Why?
|
| Leukemia, Myeloid | 2 | 2000 | 705 | 0.070 |
Why?
|
| Microscopy, Video | 1 | 2006 | 245 | 0.070 |
Why?
|
| Signal Transduction | 5 | 2019 | 23355 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2002 | 4024 | 0.070 |
Why?
|
| Perfusion | 2 | 2007 | 1353 | 0.070 |
Why?
|
| CD40 Ligand | 3 | 2002 | 527 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6310 | 0.070 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10446 | 0.060 |
Why?
|
| Triazines | 1 | 2007 | 316 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3278 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 682 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2102 | 0.060 |
Why?
|
| Multiple Myeloma | 4 | 2008 | 5147 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 3500 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 1984 | 176 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3849 | 0.060 |
Why?
|
| Stem Cell Niche | 2 | 2019 | 342 | 0.060 |
Why?
|
| Carbohydrate Sequence | 2 | 2002 | 416 | 0.060 |
Why?
|
| Stem Cell Transplantation | 2 | 2010 | 1628 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2005 | 1725 | 0.060 |
Why?
|
| Mycophenolic Acid | 2 | 2002 | 338 | 0.060 |
Why?
|
| Swainsonine | 1 | 2002 | 10 | 0.060 |
Why?
|
| Blood Cell Count | 1 | 2004 | 401 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3071 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2008 | 1055 | 0.050 |
Why?
|
| von Willebrand Factor | 2 | 2011 | 667 | 0.050 |
Why?
|
| Tunicamycin | 1 | 2002 | 112 | 0.050 |
Why?
|
| Integrin alpha5beta1 | 1 | 2002 | 38 | 0.050 |
Why?
|
| Leydig Cells | 1 | 2022 | 56 | 0.050 |
Why?
|
| Hemorheology | 1 | 2002 | 145 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1262 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2002 | 133 | 0.050 |
Why?
|
| Kidney Transplantation | 3 | 2002 | 4220 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6867 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2001 | 131 | 0.050 |
Why?
|
| Leukapheresis | 4 | 2002 | 131 | 0.050 |
Why?
|
| Bromelains | 1 | 2000 | 7 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2021 | 62 | 0.050 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 2133 | 0.050 |
Why?
|
| Male | 23 | 2022 | 348967 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 279 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 829 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2000 | 211 | 0.050 |
Why?
|
| Genes | 2 | 1984 | 1898 | 0.050 |
Why?
|
| Glycoside Hydrolases | 1 | 2000 | 134 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 1993 | 5012 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 8788 | 0.040 |
Why?
|
| Adult | 18 | 2021 | 213375 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3670 | 0.040 |
Why?
|
| Biopsy | 2 | 2020 | 6722 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 1413 | 0.040 |
Why?
|
| Pneumocystis | 1 | 1999 | 57 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2009 | 4320 | 0.040 |
Why?
|
| K562 Cells | 1 | 2001 | 621 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 437 | 0.040 |
Why?
|
| Survival Analysis | 5 | 2004 | 10248 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 1999 | 79 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18002 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 2001 | 355 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2008 | 1050 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 395 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2021 | 254 | 0.040 |
Why?
|
| Thymus Gland | 3 | 2003 | 1264 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2019 | 185 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2022 | 542 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2546 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2001 | 586 | 0.040 |
Why?
|
| Graft Survival | 3 | 2004 | 3724 | 0.040 |
Why?
|
| Consumer Health Information | 1 | 2021 | 209 | 0.040 |
Why?
|
| Middle Aged | 20 | 2021 | 212833 | 0.040 |
Why?
|
| Phylogeny | 1 | 1985 | 2788 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2019 | 318 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2004 | 6870 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1999 | 244 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13622 | 0.040 |
Why?
|
| Chlorates | 1 | 1997 | 13 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2003 | 1285 | 0.040 |
Why?
|
| Lung | 2 | 2016 | 9778 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2008 | 4196 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1999 | 427 | 0.040 |
Why?
|
| Female | 23 | 2021 | 378808 | 0.040 |
Why?
|
| Leukocyte Transfusion | 3 | 2003 | 60 | 0.040 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 1999 | 220 | 0.040 |
Why?
|
| Graft Rejection | 4 | 2005 | 4379 | 0.040 |
Why?
|
| Models, Animal | 2 | 2001 | 2166 | 0.040 |
Why?
|
| Sialomucins | 1 | 1997 | 15 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10939 | 0.040 |
Why?
|
| Steroids | 1 | 2002 | 925 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 299 | 0.040 |
Why?
|
| Salvage Therapy | 2 | 2001 | 1269 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 18124 | 0.040 |
Why?
|
| Pacemaker, Artificial | 2 | 1993 | 813 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 1984 | 2133 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 1522 | 0.040 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 59 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 1985 | 4331 | 0.040 |
Why?
|
| Microcirculation | 1 | 2001 | 1284 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2001 | 1048 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2000 | 670 | 0.040 |
Why?
|
| Sulfates | 1 | 1997 | 386 | 0.030 |
Why?
|
| DNA | 3 | 1985 | 7278 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1985 | 4319 | 0.030 |
Why?
|
| ADAM Proteins | 2 | 2011 | 242 | 0.030 |
Why?
|
| Community Health Services | 1 | 2021 | 652 | 0.030 |
Why?
|
| Interleukin-3 | 3 | 2002 | 441 | 0.030 |
Why?
|
| Peritoneum | 1 | 2016 | 226 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12134 | 0.030 |
Why?
|
| Whole-Body Irradiation | 3 | 2000 | 449 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 897 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1968 | 0.030 |
Why?
|
| Oxygen | 1 | 2007 | 4163 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2000 | 11411 | 0.030 |
Why?
|
| Base Sequence | 4 | 2008 | 12807 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1095 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 1999 | 722 | 0.030 |
Why?
|
| Drug Approval | 1 | 2021 | 742 | 0.030 |
Why?
|
| Antigens, CD1d | 2 | 2008 | 220 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2000 | 1122 | 0.030 |
Why?
|
| Cyclophosphamide | 4 | 2003 | 2238 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 20672 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 705 | 0.030 |
Why?
|
| Treatment Outcome | 9 | 2018 | 62691 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1996 | 206 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 435 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4746 | 0.030 |
Why?
|
| Leptin | 1 | 2022 | 1590 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2002 | 1064 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1871 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26293 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1583 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1584 | 0.030 |
Why?
|
| Rats | 3 | 1997 | 24259 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1781 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2000 | 4013 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1409 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 791 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1153 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 56252 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2933 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1997 | 803 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1777 | 0.020 |
Why?
|
| Testosterone | 1 | 2022 | 2391 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1984 | 1837 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2011 | 141 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2001 | 2149 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1889 | 0.020 |
Why?
|
| HLA Antigens | 3 | 2003 | 1381 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2552 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2011 | 176 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2020 | 2205 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6478 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2001 | 517 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3599 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2001 | 420 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
| Macrophages | 1 | 1984 | 5631 | 0.020 |
Why?
|
| Hymecromone | 1 | 2009 | 9 | 0.020 |
Why?
|
| Stem Cell Factor | 2 | 2000 | 219 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2021 | 1896 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1995 | 13815 | 0.020 |
Why?
|
| Combined Modality Therapy | 5 | 2000 | 8605 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3505 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 2861 | 0.020 |
Why?
|
| Splenectomy | 2 | 2000 | 392 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 2002 | 742 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8919 | 0.020 |
Why?
|
| Respiratory Muscles | 1 | 2009 | 140 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 2000 | 909 | 0.020 |
Why?
|
| Registries | 1 | 2004 | 8039 | 0.020 |
Why?
|
| United States | 2 | 2021 | 69568 | 0.020 |
Why?
|
| Integrins | 1 | 2012 | 845 | 0.020 |
Why?
|
| Dermatitis | 1 | 1989 | 195 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 9812 | 0.020 |
Why?
|
| Cyclosporine | 2 | 2000 | 782 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11348 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1984 | 570 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2007 | 108 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2000 | 3108 | 0.020 |
Why?
|
| Remission Induction | 2 | 2005 | 2378 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 1988 | 455 | 0.020 |
Why?
|
| Time Factors | 4 | 2002 | 40040 | 0.020 |
Why?
|
| Epidermis | 1 | 1989 | 526 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1375 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 21691 | 0.020 |
Why?
|
| Complement C2 | 1 | 1985 | 72 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1705 | 0.020 |
Why?
|
| Aged | 8 | 2021 | 162667 | 0.020 |
Why?
|
| Antibody Formation | 2 | 2000 | 1398 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3698 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2499 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2507 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1992 | 1539 | 0.020 |
Why?
|
| Collodion | 1 | 1984 | 34 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6391 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1984 | 212 | 0.020 |
Why?
|
| Child | 2 | 2021 | 77029 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1993 | 1542 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 903 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 1059 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8292 | 0.010 |
Why?
|
| Haplotypes | 2 | 2002 | 2783 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1993 | 1271 | 0.010 |
Why?
|
| Autoradiography | 1 | 1984 | 764 | 0.010 |
Why?
|
| Protozoan Infections | 1 | 2003 | 39 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1984 | 365 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 1993 | 1441 | 0.010 |
Why?
|
| Trachea | 1 | 2009 | 1074 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3487 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 7716 | 0.010 |
Why?
|
| Trisaccharides | 1 | 2002 | 50 | 0.010 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2002 | 102 | 0.010 |
Why?
|
| Cell Separation | 1 | 2008 | 1740 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4981 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 1424 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 79 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2007 | 848 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 353 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2002 | 315 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1984 | 558 | 0.010 |
Why?
|
| Aspergillosis | 1 | 2003 | 235 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 231 | 0.010 |
Why?
|
| Platelet Count | 1 | 2004 | 780 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2000 | 40 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2001 | 257 | 0.010 |
Why?
|
| Phenotype | 3 | 2000 | 16300 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 2000 | 79 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 2023 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15510 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8274 | 0.010 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2000 | 59 | 0.010 |
Why?
|
| Atovaquone | 1 | 1999 | 58 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1583 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9598 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7861 | 0.010 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2000 | 109 | 0.010 |
Why?
|
| Species Specificity | 1 | 1984 | 2481 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2894 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1992 | 6425 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6609 | 0.010 |
Why?
|
| Adolescent | 3 | 2021 | 85409 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2634 | 0.010 |
Why?
|
| Software | 1 | 1992 | 4425 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1984 | 2433 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 2000 | 492 | 0.010 |
Why?
|
| Chimera | 1 | 1999 | 488 | 0.010 |
Why?
|
| Neutropenia | 1 | 2003 | 888 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2001 | 800 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12760 | 0.010 |
Why?
|
| Blood | 1 | 2000 | 597 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2003 | 710 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1996 | 5632 | 0.010 |
Why?
|
| Busulfan | 1 | 1997 | 262 | 0.010 |
Why?
|
| Carboplatin | 1 | 2000 | 799 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1778 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 260 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2000 | 617 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2001 | 3118 | 0.010 |
Why?
|
| Living Donors | 1 | 1999 | 617 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4575 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6364 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1763 | 0.010 |
Why?
|
| RNA | 1 | 1984 | 2727 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1989 | 9132 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1601 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 1992 | 5003 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3769 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 627 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35274 | 0.010 |
Why?
|
| Alleles | 1 | 1984 | 6939 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 1992 | 182 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2004 | 76632 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 2937 | 0.010 |
Why?
|
| Peptides | 1 | 2001 | 4392 | 0.010 |
Why?
|
| Mortality | 1 | 2000 | 2851 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2001 | 3066 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 7897 | 0.000 |
Why?
|
| Heart Diseases | 1 | 2000 | 2781 | 0.000 |
Why?
|
| Genotype | 1 | 2000 | 12950 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 38941 | 0.000 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2000 | 5148 | 0.000 |
Why?
|
| Equipment Design | 1 | 1993 | 3576 | 0.000 |
Why?
|
| Hemolysis | 1 | 1984 | 420 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 19787 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2003 | 40385 | 0.000 |
Why?
|
| Catheter Ablation | 1 | 1992 | 2737 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15191 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1999 | 53036 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 71972 | 0.000 |
Why?
|